GO:0043235 signaling receptor complex: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0043235 signaling receptor complex is a cellular component defined as any protein complex that binds a signaling molecule such as a hormone, neurotransmitter, molecular pattern recognition receptor (PAMPs and DAMPs), or an intracellular messenger to initiate a change in cell function.
• Signaling receptor complexes are central to signal transduction and are formed by diverse receptor families including G protein-coupled receptors (GPCRs), cytokine receptors, antigen receptors, and receptor tyrosine kinases [1, 2, 4].
• Assembly and dynamics of these complexes are often transient and regulated, as exemplified by the sequential formation of TNF receptor I signaling complexes during apoptosis.
• Dysregulation of signaling receptor complexes underlies many human diseases, including cancer, immune disorders, and neurological conditions [3, 7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise interrogation of receptor complex components and their signaling outputs.
• Understanding signaling receptor complex biology informs drug discovery, as these complexes are major targets for therapeutic intervention [1, 3].
Description
The Gene Ontology (GO) term GO:0043235, signaling receptor complex, describes a cellular component comprising any protein complex that binds a signaling molecule to initiate a change in cell function. This term encompasses a wide array of receptor assemblies, from G protein-coupled receptors (GPCRs) that respond to hormones and neurotransmitters to cytokine receptors such as TNF receptor I that mediate immune signaling. Signaling receptor complexes are fundamental to intercellular communication and cellular responses to environmental cues. Their precise composition and regulation are critical for normal physiology, and their dysfunction is implicated in numerous diseases [3, 7]. Researchers studying signal transduction, receptor pharmacology, and disease mechanisms require a clear understanding of these complexes. This article provides a comprehensive overview of the definition, structure, mechanisms, key genes, and research methodologies associated with GO:0043235, with a focus on CRISPR-based approaches for functional studies.
signaling receptor complex At A Glance
| GO ID | GO:0043235 |
|---|---|
| GO term | signaling receptor complex |
| Ontology | cellular_component |
| Synonym | receptor complex |
| Major function | Binds signaling molecules (hormones, neurotransmitters, PAMPs, DAMPs, intracellular messengers) to initiate changes in cell function |
| Definition source | QuickGO |
| Related processes | Signal transduction, immune response, neurotransmission, apoptosis |
| Example receptors | GPCRs, TNF receptor I, T cell receptor, Eph receptors |
What Is GO:0043235?
According to the QuickGO definition, GO:0043235 signaling receptor complex refers to any protein complex that binds a signaling molecule such as a hormone, neurotransmitter, molecular pattern recognition receptor (PAMPs and DAMPs), or an intracellular messenger to initiate a change in cell function. This definition captures the essential role of these complexes as molecular sensors that convert extracellular or intracellular signals into cellular responses. The term is a cellular component annotation, indicating that it describes a physical entity within the cell rather than a process or function. Synonyms include receptor complex. The definition emphasizes the binding of diverse signaling molecules, reflecting the broad range of receptors that fall under this category, including GPCRs, cytokine receptors, and antigen receptors [1, 2, 4].
Why Is signaling receptor complex Important in Cell Biology?
Signaling receptor complexes are essential for cellular communication and are involved in virtually every aspect of physiology, from neurotransmission to immune defense. Their dysfunction is linked to a wide range of diseases, including cancer, autoimmune disorders, and neurodegenerative diseases [3, 7]. Understanding how these complexes assemble, function, and are regulated provides critical insights into disease mechanisms and identifies potential therapeutic targets. Moreover, the dynamic nature of these complexes, as seen in the sequential formation of TNF receptor I signaling complexes, highlights the importance of studying their temporal and spatial regulation. Research on signaling receptor complexes is therefore fundamental to both basic biology and translational medicine.
• Signaling receptor complexes mediate responses to hormones and neurotransmitters, controlling processes such as metabolism, mood, and cardiovascular function [1, 3].
• They are key players in immune recognition and activation, including T cell receptor signaling and cytokine responses [2, 4, 5].
• Dysregulation of receptor complexes contributes to cancer development and progression, making them targets for targeted therapies.
• Neurological and psychiatric disorders often involve altered signaling at receptor complexes, such as serotonin receptors.
• Receptor complexes are involved in developmental processes, including axon guidance and tissue patterning.
• They serve as models for studying protein-protein interactions, allostery, and signal integration [1, 6].
• Kinetic proofreading mechanisms in receptor complexes ensure signaling specificity and fidelity.
• CRISPR screens can identify novel components and regulators of signaling receptor complexes, accelerating drug discovery.
• Understanding receptor complex assembly can inform the design of biologics and small molecules that modulate signaling.
• Receptor complexes are often hijacked by pathogens, making them relevant to infectious disease research.
Core Biology of signaling receptor complex
What Happens During signaling receptor complex Activation?
In simple terms: When a signal molecule binds to a receptor complex, it triggers a series of events inside the cell.
Activation of a signaling receptor complex begins with the binding of a specific ligand, such as a hormone or neurotransmitter, to the extracellular or intracellular domain of the receptor. This binding induces conformational changes that propagate through the complex, leading to the recruitment and activation of downstream signaling proteins. For example, GPCRs undergo structural rearrangements that facilitate G protein coupling and activation. In the case of TNF receptor I, ligand binding promotes the assembly of a membrane-proximal complex that subsequently internalizes and forms a second cytosolic complex, initiating apoptosis. These events are highly regulated and often involve post-translational modifications and changes in membrane microdomains.
Assembly and Composition of signaling receptor complex
In simple terms: Receptor complexes are made of multiple protein subunits that come together to form a functional unit.
Signaling receptor complexes are composed of one or more receptor subunits, which can be homomeric or heteromeric, along with associated adaptor proteins and signaling enzymes. For instance, the T cell receptor complex consists of variable antigen-binding subunits and invariant signaling subunits, which assemble with adaptor proteins to transduce signals [4, 5]. GPCRs are typically composed of a single polypeptide chain that forms a seven-transmembrane domain, but they can dimerize or associate with accessory proteins. The composition of these complexes is dynamic and can change upon ligand binding or during cellular activation, as observed in T cell development.
Molecular Mechanism of signaling receptor complex Signaling
In simple terms: The receptor complex acts like a molecular switch that turns on specific signaling pathways inside the cell.
At the molecular level, signaling receptor complexes function by coupling ligand binding to the activation of intracellular signaling cascades. This often involves the activation of associated kinases or G proteins, which then propagate the signal through phosphorylation cascades or second messenger production. For example, GPCRs activate heterotrimeric G proteins, leading to the modulation of effector enzymes such as adenylyl cyclase. Receptor tyrosine kinases, such as Eph receptors, undergo autophosphorylation upon ligand binding, creating docking sites for SH2 domain-containing proteins. The kinetic proofreading model explains how these complexes achieve high specificity by requiring multiple sequential interactions before full activation.
Regulation of signaling receptor complex Activity
In simple terms: Cells control receptor complex activity to avoid over- or under-signaling.
Regulation of signaling receptor complexes occurs at multiple levels, including ligand availability, receptor expression, post-translational modifications, and feedback loops. For instance, GPCR signaling is terminated by receptor phosphorylation and arrestin-mediated internalization. In T cells, the composition of the TCR signaling complex changes during development and activation, influencing signal strength and outcome. Additionally, the formation of distinct signaling complexes, such as the two sequential complexes in TNF receptor I signaling, provides a mechanism for temporal regulation of cell fate decisions. Dysregulation of these control mechanisms can lead to pathological conditions [3, 7].
Signaling Receptor Complexes in Disease
In simple terms: When receptor complexes malfunction, they can cause or contribute to various diseases.
Alterations in signaling receptor complexes are associated with numerous human diseases. For example, mutations in GPCRs can lead to endocrine disorders or cancer. Overexpression or constitutive activation of Eph receptors is implicated in tumor progression and metastasis. In the nervous system, dysfunction of serotonin receptors is linked to mood disorders and schizophrenia. Furthermore, defects in immune receptor signaling complexes can result in immunodeficiency or autoimmunity [4, 5]. Understanding the specific molecular defects in these complexes is essential for developing targeted therapies.
Key Genes Involved in GO:0043235 signaling receptor complex
The following table lists key genes and proteins that are components or regulators of signaling receptor complexes, along with their major roles and research relevance.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADRB2 | Beta-2 adrenergic receptor, a GPCR that binds catecholamines | Model for GPCR signaling and drug discovery |
| TNFRSF1A | TNF receptor I, forms signaling complexes in apoptosis and inflammation | Studied for sequential complex formation and disease mechanisms |
| HTR1A | Serotonin receptor 1A, a GPCR for serotonin | Target for neuropsychiatric disorders |
| CD3E | Component of the T cell receptor complex, involved in signal transduction | Key for T cell development and activation studies [4, 5] |
| LCK | Src-family kinase that associates with TCR complex | Regulates TCR signaling and is a drug target [4, 5] |
| EPHA2 | Eph receptor A2, a receptor tyrosine kinase | Implicated in cancer and developmental processes |
| SMAD2 | Intracellular signal transducer for TGF-beta receptors | Mediates TGF-beta signaling from receptor complexes |
| SMAD3 | Intracellular signal transducer for TGF-beta receptors | Mediates TGF-beta signaling from receptor complexes |
| ARRB1 | Beta-arrestin 1, regulates GPCR desensitization | Modulates GPCR signaling and trafficking |
| GNAI1 | G protein alpha subunit, couples to GPCRs | Mediates GPCR signaling to effectors |
| JAK2 | Janus kinase 2, associates with cytokine receptors | Key for cytokine signaling and myeloproliferative disorders |
| STAT3 | Signal transducer and activator of transcription 3 | Downstream of cytokine receptor complexes |
| GRB2 | Adaptor protein in receptor tyrosine kinase signaling | Links receptor complexes to MAPK pathway |
| PIK3CA | Catalytic subunit of PI3K, activated by receptor complexes | Frequently mutated in cancer |
| PLCG1 | Phospholipase C gamma 1, activated by receptor tyrosine kinases | Mediates calcium signaling from receptor complexes |
| PRKCA | Protein kinase C alpha, downstream of GPCR and RTK signaling | Regulates diverse cellular responses |
| SRC | Non-receptor tyrosine kinase, interacts with receptor complexes | Modulates signaling and is a cancer target |
| CBL | E3 ubiquitin ligase that regulates receptor tyrosine kinases | Controls receptor complex downregulation |
How Is signaling receptor complex Regulated?
Signaling receptor complex activity is tightly regulated through mechanisms such as ligand-induced conformational changes, post-translational modifications (e.g., phosphorylation, ubiquitination), and feedback loops. For GPCRs, phosphorylation by GRKs and binding of arrestins desensitize the receptor and promote internalization. In T cells, the composition of the TCR signaling complex and its association with membrane microdomains change during development and activation, affecting signal strength. The kinetic proofreading model describes how sequential interactions within receptor complexes ensure signaling specificity. Additionally, the formation of distinct signaling complexes, such as the two sequential complexes in TNF receptor I signaling, provides temporal regulation of cell fate. These regulatory mechanisms are crucial for maintaining cellular homeostasis and preventing disease.
signaling receptor complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EPHA2 | Cancer progression and metastasis | Knockout and point mutation in cancer cell lines |
| HTR1A | Depression and anxiety disorders | Knock-in of human polymorphisms in mice |
| TNFRSF1A | Autoinflammatory diseases | Knockout mice and knock-in of patient mutations |
| CD3E | Immunodeficiency | Knockout in T cell lines and primary cells |
| SMAD2/3 | Cancer and fibrosis | Knockout and overexpression in epithelial cells |
Signaling Receptor Complexes in Cancer
Dysregulation of signaling receptor complexes is a hallmark of many cancers. For example, overexpression or activating mutations in receptor tyrosine kinases such as Eph receptors can drive tumor growth and metastasis. GPCRs are also implicated in cancer, with aberrant signaling promoting proliferation and survival. Targeting these complexes with small molecule inhibitors or antibodies has proven successful in several malignancies, underscoring their clinical relevance.
Signaling Receptor Complexes in Neurological Disorders
In the nervous system, signaling receptor complexes mediate neurotransmission and neuromodulation. Dysfunction of serotonin receptors, for instance, is associated with depression, anxiety, and schizophrenia. Alterations in GPCR signaling are also linked to neurodegenerative diseases such as Parkinson's and Alzheimer's, where receptor complexes may contribute to disease progression.
Signaling Receptor Complexes in Immune Disorders
Immune receptor signaling complexes, such as the T cell receptor and cytokine receptors, are critical for immune responses. Defects in these complexes can lead to immunodeficiency or autoimmunity [4, 5]. For example, mutations affecting TCR signaling components cause severe combined immunodeficiency, while dysregulated cytokine receptor signaling contributes to autoimmune diseases like rheumatoid arthritis.
From signaling receptor complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a receptor subunit abolish signaling? | Knockout cell lines (e.g., CRISPR-Cas9) |
| Does a specific point mutation affect ligand binding? | Point mutation knock-in cell lines |
| How does a fusion protein affect receptor complex assembly? | Knock-in of tagged receptor (e.g., GFP) |
| Does overexpression of a receptor enhance signaling? | Overexpression cell lines |
| Which genes regulate receptor complex stability? | CRISPR library screening |
| What is the interactome of a receptor complex? | Bioinformatics and proteomics |
How to Study the signaling receptor complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation (Co-IP) | Protein-protein interactions | Identifying components of receptor complexes |
| Mass spectrometry (MS) | Protein composition and modifications | Mapping dynamic changes in receptor complexes |
| FRET/BRET | Real-time conformational changes and interactions | Studying receptor activation and assembly |
| CRISPR knockout screening | Gene function on a genome-wide scale | Discovering regulators of receptor signaling |
| RNA-seq | Transcriptional changes | Assessing downstream effects of receptor activation |
| Phosphoproteomics | Phosphorylation events | Mapping signaling pathways activated by receptor complexes |
| Surface plasmon resonance (SPR) | Binding kinetics | Measuring ligand-receptor interactions |
Proteomic Analysis of Receptor Complexes
Mass spectrometry-based proteomics, including immunoprecipitation followed by mass spectrometry (IP-MS), enables the identification of components and post-translational modifications of signaling receptor complexes. This approach can reveal dynamic changes in complex composition upon ligand stimulation [1, 2].
Imaging and Live-Cell Dynamics
Fluorescence microscopy, including FRET and BRET, allows real-time visualization of receptor complex assembly and trafficking in live cells. These techniques have been instrumental in understanding the spatiotemporal regulation of GPCRs and immune receptors [1, 5].
CRISPR Screening for Receptor Complex Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that modulate signaling receptor complex activity. Such screens have uncovered novel regulators of GPCR signaling and immune receptor pathways, providing potential therapeutic targets [1, 4].
Bioinformatics and Pathway Analysis
Computational analyses of transcriptomic and proteomic data, combined with pathway databases, help elucidate the signaling networks downstream of receptor complexes. These methods can predict crosstalk and identify disease-associated modules [3, 7].
How CRISPR Can Be Used to Study GO:0043235 signaling receptor complex
Knockout
CRISPR-Cas9 knockout of genes encoding receptor subunits or signaling components can abolish complex formation and function, providing definitive evidence for their roles. For example, knocking out CD3E in T cells disrupts TCR signaling and development [4, 5].
Point Mutation
Introducing specific point mutations via CRISPR base editing or homology-directed repair allows researchers to dissect the functional impact of disease-associated variants in receptor genes. This approach has been used to study GPCR polymorphisms and their effects on signaling.
Knock-in
Knock-in of tagged receptors (e.g., GFP, HA) or reporter genes enables visualization and purification of receptor complexes. This is particularly useful for studying dynamic assembly and trafficking in live cells [1, 5].
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase receptor levels to study gain-of-function effects and signaling amplification. Overexpression models are valuable for drug screening and identifying downstream targets.
How EDITGENE Supports signaling receptor complex Research
Researchers studying signaling receptor complex-related genes often need to determine whether a candidate gene is causally involved in receptor assembly, signaling, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for signaling receptor complex research.
Frequently Asked Questions About signaling receptor complex
What is GO:0043235 signaling receptor complex?
GO:0043235 is a Gene Ontology cellular component term defined as any protein complex that binds a signaling molecule such as a hormone, neurotransmitter, PAMP, DAMP, or intracellular messenger to initiate a change in cell function.
What genes are involved in signaling receptor complexes?
Genes encoding receptor subunits (e.g., ADRB2, TNFRSF1A, CD3E), adaptor proteins (e.g., GRB2), kinases (e.g., LCK, JAK2), and G proteins (e.g., GNAI1) are commonly involved [1, 2, 4].
How are signaling receptor complexes assembled?
Assembly is driven by ligand binding and protein-protein interactions, often involving conformational changes and recruitment of adaptors, as seen in GPCRs and TNF receptor I [1, 2].
What diseases are linked to signaling receptor complex dysfunction?
Diseases include cancer, neurological disorders (e.g., depression), and immune disorders (e.g., autoimmunity) [3, 7].
What methods are used to study signaling receptor complexes?
Common methods include co-immunoprecipitation, mass spectrometry, FRET/BRET, and CRISPR screening [1, 5].
How can CRISPR help study signaling receptor complexes?
CRISPR enables knockout, point mutation, knock-in, and overexpression of receptor genes to dissect their functions and interactions [4, 5].
What is the role of GPCRs in signaling receptor complexes?
GPCRs are a major class of signaling receptor complexes that respond to hormones and neurotransmitters and activate G proteins.
What is kinetic proofreading in receptor signaling?
Kinetic proofreading is a mechanism that ensures signaling specificity by requiring multiple sequential interactions within receptor complexes before full activation.
Can signaling receptor complexes be targeted therapeutically?
Yes, many drugs target receptor complexes, including GPCRs and receptor tyrosine kinases, for cancer and other diseases [1, 7].
What are the challenges in studying signaling receptor complexes?
Challenges include their dynamic and transient nature, heterogeneity, and the need for sensitive techniques to capture transient interactions [1, 2].
Conclusion
GO:0043235 signaling receptor complex represents a fundamental cellular component that mediates diverse signaling pathways essential for normal physiology and disease. Understanding the structure, assembly, and regulation of these complexes is critical for basic research and therapeutic development. CRISPR-based models and advanced screening technologies offer powerful tools to interrogate receptor complex biology. EDITGENE provides comprehensive services to support these investigations, from gene editing to bioinformatics.
References
- 1. Hilger D et al.. 2018. Structure and dynamics of GPCR signaling complexes.. Nat Struct Mol Biol 25(1):4-12 PMID: 29323277
- 2. Micheau O et al.. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.. Cell 114(2):181-90 PMID: 12887920
- 3. Sharp T et al.. 2020. Central 5-HT receptors and their function; present and future.. Neuropharmacology 177:108155 PMID: 32522572
- 4. Tomlinson MG et al.. 2000. Lymphocytes with a complex: adapter proteins in antigen receptor signaling.. Immunol Today 21(11):584-91 PMID: 11094263
- 5. Leitenberg D et al.. 2001. Changes in the T cell receptor macromolecular signaling complex and membrane microdomains during T cell development and activation.. Semin Immunol 13(2):129-38 PMID: 11308296
- 6. Goldstein B et al.. 2008. Kinetic proofreading model.. Adv Exp Med Biol 640:82-94 PMID: 19065786
- 7. Lisabeth EM et al.. 2013. Eph receptor signaling and ephrins.. Cold Spring Harb Perspect Biol 5(9) PMID: 24003208
- 8. Wrana JL. 2000. Crossing Smads.. Sci STKE 2000(23):re1 PMID: 11752591
